Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v1-EN
Language English English
Date Updated 2024-04-03 2024-04-02
Drug Identification Number 02426307 02426307
Brand name SANDOZ RIVASTIGMINE PATCH 10 SANDOZ RIVASTIGMINE PATCH 10
Common or Proper name RIVASTIGMINE PATCH 10 RIVASTIGMINE PATCH 10
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients RIVASTIGMINE RIVASTIGMINE
Strength(s) 9.5MG 9.5MG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 30TTSM 30TTSM
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-02 2024-04-02
Estimated end date 2024-04-26 2024-04-26
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments